Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Therapeuticsmd Inc (TXMD)

Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,148
  • Shares Outstanding, K 11,574
  • Annual Sales, $ 1,760 K
  • Annual Income, $ -2,180 K
  • EBIT $ -2 M
  • EBITDA $ -2 M
  • 60-Month Beta 0.56
  • Price/Sales 7.74
  • Price/Cash Flow 43.30
  • Price/Book 0.87

Options Overview Details

View History
  • Implied Volatility 431.57% (+346.62%)
  • Historical Volatility 33.89%
  • IV Percentile 71%
  • IV Rank 30.29%
  • IV High 1,298.47% on 03/09/26
  • IV Low 54.84% on 03/16/26
  • Expected Move (DTE 15) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 21
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 1,107
  • Open Int (30-Day) 1,181
  • Expected Range 2.00 to 2.00

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.90 +5.26%
on 03/31/26
2.40 -16.67%
on 03/25/26
-0.24 (-10.71%)
since 03/02/26
3-Month
1.63 +22.90%
on 01/05/26
2.95 -32.20%
on 01/27/26
+0.35 (+21.21%)
since 01/02/26
52-Week
0.84 +138.10%
on 04/10/25
2.95 -32.20%
on 01/27/26
+1.00 (+100.00%)
since 04/02/25

Most Recent Stories

More News
TherapeuticsMD Announces Full Year 2025 Financial Results

TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December...

TXMD : 2.00 (unch)
TherapeuticsMD: Q3 Earnings Snapshot

TherapeuticsMD: Q3 Earnings Snapshot

TXMD : 2.00 (unch)
TherapeuticsMD Announces Third Quarter 2025 Financial Results

TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the three months ended September...

TXMD : 2.00 (unch)
TherapeuticsMD: Q2 Earnings Snapshot

TherapeuticsMD: Q2 Earnings Snapshot

TXMD : 2.00 (unch)
TherapeuticsMD Announces Second Quarter 2025 Financial Results

TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the three months ended June...

TXMD : 2.00 (unch)
TherapeuticsMD: Q1 Earnings Snapshot

TherapeuticsMD: Q1 Earnings Snapshot

TXMD : 2.00 (unch)
TherapeuticsMD: Q3 Earnings Snapshot

TherapeuticsMD: Q3 Earnings Snapshot

TXMD : 2.00 (unch)
TherapeuticsMD: Q2 Earnings Snapshot

TherapeuticsMD: Q2 Earnings Snapshot

TXMD : 2.00 (unch)
TherapeuticsMD: Q1 Earnings Snapshot

TherapeuticsMD: Q1 Earnings Snapshot

TXMD : 2.00 (unch)
TherapeuticsMD: Q3 Earnings Snapshot

TherapeuticsMD: Q3 Earnings Snapshot

TXMD : 2.00 (unch)

Business Summary

TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health...

See More

Key Turning Points

3rd Resistance Point 2.29
2nd Resistance Point 2.23
1st Resistance Point 2.11
Last Price 2.00
1st Support Level 1.94
2nd Support Level 1.87
3rd Support Level 1.76

See More

52-Week High 2.95
Fibonacci 61.8% 2.14
Last Price 2.00
Fibonacci 50% 1.89
Fibonacci 38.2% 1.65
52-Week Low 0.84

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.